COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Incorporated

21/03/2018 - 13:30

MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, announced today that its wholly owned subsidiary, TumorGenesis Inc., [...]

Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%

21/03/2018 - 13:30

BUENA, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]

Bespoke Extracts’ Sponsored Sportsbike Racer Robertino Pietri Takes Third Place at 77th Annual Running of the Daytona 200

21/03/2018 - 13:07

SUNNY ISLES, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTC Pink:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, is pleased to announce that in the debut of its [...]

Vectura Group plc: 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products

21/03/2018 - 13:01

Vectura Group plc 2017 Preliminary Results - Performance in-line with expectations, with strong in-market growth from key inhaled products - Chippenham, UK - 21 March 2018: Vectura Group plc (LSE: VEC) ("Vectura", "the [...]

Enzymatica AB: Notice of annual general meeting in Enzymatica AB (publ)

21/03/2018 - 13:01

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. Press release Lund on March 21, 2018 Notice of annual [...]

Sun BioPharma Provides Business Update and Files Annual Report for 2017

21/03/2018 - 13:01

Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel to begin patient enrollment early in 2 nd Quarter Raised $1.3M in private financing MINNEAPOLIS, March 21, 2018 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. ( [...]

Achaogen Announces Date of FDA Advisory Committee Meeting for Plazomicin

21/03/2018 - 13:00

-- Meeting planned for May 2, 2018 -- SOUTH SAN FRANCISCO, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials [...]

Avinger Enters into Settlement Agreement for All Outstanding Securities Class Action Litigation

21/03/2018 - 13:00

REDWOOD CITY, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that [...]

BioSyent Releases Results for Fourth Quarter and Full Year 2017

21/03/2018 - 13:00

TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) released today a summary of its financial results for the three and twelve months ended December 31, 2017. Key highlights include: [...]

Albireo to Present at 17th Annual Needham & Company Healthcare Conference

21/03/2018 - 13:00

BOSTON, March 21, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Ron Cooper, President [...]

BioSig Technologies Announces Participation in Bates College’s Purposeful Work Initiative

21/03/2018 - 13:00

Santa Monica, CA, March 21, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

Incysus to Present at BioCentury Future Leaders Conference

21/03/2018 - 13:00

NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, announced today that [...]

Clearside Biomedical to Present at the 17th Annual Needham Healthcare Conference

21/03/2018 - 13:00

ALPHARETTA, Ga., March 21, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases [...]

Caelum Biosciences Announces Clinical Data on CAEL-101 in AL Amyloidosis Selected for Oral Presentation at 16th International Symposium on Amyloidosis

21/03/2018 - 13:00

NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a Fortress Biotech, Inc. (NASDAQ: FBIO ) Company developing treatments for rare and life-threatening diseases, today announced that the [...]

Arch Biopartners Granted Pre-Ind Meeting With FDA for Candidate Drug to Prevent Acute Kidney Injury

21/03/2018 - 13:00

TORONTO, March 21, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB: ACHFF ), announced today that a Pre-Investigational New Drug (Pre-IND) meeting with the U.S. Food and [...]

Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative

21/03/2018 - 13:00

TORONTO, ON, March 21, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals, Inc. (OTC: EAPH), announces it has initiated discussions for the development of a blockchain platform and cryptocurrency that will streamline the [...]

Chiesi to Become Presenting Sponsor of North Carolina Football Club’s Spread Your Wings Foundation

21/03/2018 - 13:00

CARY, N.C., March 21, 2018 (GLOBE NEWSWIRE) -- The North Carolina Football Club announced today that Chiesi (key-A-zee), a Cary-based specialty pharmaceutical company, will become the presenting sponsor of the club’s [...]

Checkpoint Therapeutics Initiates Dose Expansion Portion of Phase 1 Trial of Anti-PD-L1 Antibody CK-301

21/03/2018 - 13:00

NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT ), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]

Cidara Therapeutics Provides Clinical Data Updates for its Lead Antifungal Rezafungin

21/03/2018 - 13:00

Additional data and analyses from STRIVE Phase 2 clinical trial confirm positive efficacy results in both rezafungin arms Definitive Phase 1 QT clinical trial showed no cardiac abnormalities SAN DIEGO, March 21, 2018 ( [...]